GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

Cannabis edibles and alcohol together produced stronger driving impairment than either substance alone, while standard field ...

Australia has made major progress in curbing drink driving. Decades of random breath testing, enforcement and powerful social media campaigns have cut alcohol-related road deaths significantly. Yet ...

Evidence continues to mount suggesting that GLP-1 drugs may help people cut back on cigarettes, drinking and opioid use. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

A new study published in the journal Neuron provides evidence that the brain stores competing memories of alcohol use and the ...